The latest research study “Cancer Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the Global Cancer Vaccines Market size reached US$ 5.43 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 10.72 Billion by 2027 exhibiting a CAGR of 11.70% during 2022-2027.
Covid-19 Impact:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Industry Definition and Application:
Cancer vaccines, alternatively referred to as immunotherapy, represent medicines that help the immune system of the body to identify and destroy cancer cells. They can be broadly categorized into preventive and therapeutic vaccines. These cancer vaccines aid in eliminating cancer caused by oncovirus, offering protection from human papilloma virus (HPV), and stimulating the adaptive immune systems by using tumor antigens. They have the advantages of low toxicity, exquisite specificity, and potential for durable treatment effect. Consequently, cancer vaccines are in high demand among consumers across the globe.
Download free sample brochure: https://www.imarcgroup.com/cancer-vaccines-market/requestsample
Cancer Vaccines Market Trends and Drivers:
The elevating prevalence of cancer, owing to the rising consumption of tobacco-based products and unhealthy lifestyles, is primarily driving the cancer vaccines market. Besides this, the launch of several policies by the government bodies aimed at promoting novel vaccine technologies for cancer and the introduction of viral recombinant vaccine treatments are acting as significant growth-inducing factors.
Moreover, the growing geriatric population and the expanding human papilloma virus (HPV) infections are positively influencing the global market. Additionally, the inflating investments in research and development activities (R&D) by leading market players to gain a competitive edge and the escalating advancement of healthcare infrastructure, especially in developing countries, are expected to stimulate the cancer vaccines market in the coming years.
Click here to view detailed information with table of content: https://www.imarcgroup.com/cancer-vaccines-market
|
Cancer Vaccines Market Report Scope |
|
|
Report Coverage |
Details |
|
Market size value in 2021 |
US$ 5.43 Billion |
|
Market forecast in 2027 |
US$ 10.72 Billion |
|
Growth Rate |
CAGR of 11.70% from 2022 to 2027 |
|
Base year for estimation |
2021 |
|
Historical data |
2016-2021 |
|
Forecast period |
2022-2027 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Type, Technology, Indication and End User |
|
Regional scope |
North America, Europe, Asia-Pacific, Latin America, Middle East and Africa |
|
Key companies profiled |
Anixa Biosciences Inc., Dendreon Pharmaceuticals LLC, Dynavax Technologies Corporation, GSK plc, Merck & Co. Inc., Moderna Inc., OSE Immunotherapeutics, Providence Therapeutics, Sanofi S.A., UbiVac Inc. and Vaccitech plc. |
|
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period, |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Report Segmentation:
The report has been segmented the market into following categories:
Breakup by Type:
• Preventive Cancer Vaccines
• Therapeutic Cancer Vaccines
Breakup by Technology:
• Dendritic Cells Cancer Vaccines
• Recombinant Cancer Vaccines
• Antigen/Adjuvant Cancer Vaccines
• Viral Vector and DNA Cancer Vaccines
• Whole-cell Cancer Vaccines
Breakup by Indication:
• Cervical Cancer
• Prostate Cancer
• Others
By Geography:
• North America
o United States
o Canada
• Asia-Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others
• Latin America
o Brazil
o Mexico
o Others
• Middle East and Africa
List of Major Key Players:
The major players in the market are Anixa Biosciences Inc., Dendreon Pharmaceuticals LLC, Dynavax Technologies Corporation, GSK plc, Merck & Co. Inc., Moderna Inc., OSE Immunotherapeutics, Providence Therapeutics, Sanofi S.A., UbiVac Inc. and Vaccitech plc..
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
